NCT04487405View on ClinicalTrials.gov

A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants

TerminatedOBSERVATIONAL
Enrollment

721

Participants

Timeline

Start Date

June 25, 2020

Primary Completion Date

December 15, 2023

Study Completion Date

December 15, 2023

Conditions
Adnexal Mass
Interventions
DEVICE

OVAnex

OVAnex is a multivarite index assay assessing ovarian cancer risk

Trial Locations (9)

11040

Square Care Health, New Hyde Park

11042

Northwell Health, New Hyde Park

17601

May Grant OB/GYN, Lancaster

31901

MidTown OBGYN, Columbus

33461

Altus Research, Lake Worth

45211

Seven Hills Clinical Research Group, Cincinnati

55344

Premier OBGYN of Minnesota, Eden Prairie

78748

Hill Country OBGYN Associates, Austin

85224

Women's Health Arizona, Chandler

Sponsors
All Listed Sponsors
lead

Aspira Women's Health

INDUSTRY